SRP-1001 — Interim data
H2 2026
We shared early results from this trial in March 2026, and expect to share further data in the second half of 2026.Source filing
SRPT biotech catalysts & pipeline
SAREPTA THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
ELEVIDYS (delandistrogene moxeparvovec-rokl) — Clinical data readout
in Q1 2027
For ELEVIDYS, full enrollment of ENDEAVOR Cohort 8 expected by year-end 2026 and 12-week data from the full cohort in Q1 2027.Source filing